FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Philips Recalls Ventilators Over Contaminated Plastic

Philips Respironics recalls (Class 1) certain BiPAP (bi-level positive airway pressure) ventilators that may contain a plastic contaminated with a non...

latest-news-card-1
Human Drugs

Naloxone Guidance Attempts to Ease Availability

FDA releases an immediately-in-effect guidance entitled Exemption and Exclusion from Certain Requirements of the Drug Supply Chain Security Act (DSCSA...

latest-news-card-1
Federal Register

Info Collection on Abbreviated Animal Drug Apps

Federal Register notice: FDA sends to OMB an information collection extension for abbreviated new animal drug applications.

latest-news-card-1
Federal Register

Arthritis Advisory Committee Renewed for 2 Years

Federal Register notice: FDA renews its Arthritis Advisory Committee for an additional two years.

latest-news-card-1
Federal Register

Final Guide on 510(k) Template for eSubmission

Federal Register notice: FDA makes available a final guidance entitled Electronic Submission Template for Medical Device 510(k) Submissions.

latest-news-card-1
Human Drugs

Expand RTOR to Cell, Tissue Products: PhRMA

PhRMA says the FDA Oncology Center of Excellence Real-Time Oncology Review (RTOR) program should be expanded to include tissue and cell products regul...

latest-news-card-1
Human Drugs

Comments on Therapeutic Equivalence Draft Guidance

Five stakeholders comment on an FDA draft guidance on therapeutic equivalence evaluations.

latest-news-card-1
Marketing

OPDP to Study TV Ad Endorsers

The CDER Office of Prescription Drug Promotion says it wants to expand a current study on endorsers in print and Internet ads to cover TV spots.

Marketing

2 Prescription Drug Promotion Studies Proposed

The CDER Office of Prescription Drug Promotion proposes to study consumer and healthcare provider perceptions about drugs that come with medication tr...

Medical Devices

FDA Approves Medtronic Indication for Onyx Stents

FDA approves two Medtronic drug-eluting stents for use in treating non-left main bifurcation lesions in the heart.